VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gene Voss who wrote (750)	10/8/1997 1:36:00 PM
From: Tunica Albuginea	of 23519

Gene , again Re:Pfizer desperately needs PR campaign to bolster stock. In talking with some Inernists it now appears that PFE's drug Zithromax, may take a hit in the next 2 years because one of the most frequent causes of community-acquired pneumonis, the organism Pneumococcus Pneumoniae iithromax is one.So people are starting to swith to the fluoroquinolones such as Cipro and PFE's new one, " Trovan" ( Trovafloxacin ).The problem for PFE though is the competition:Trovan will compete with Cipro, Floxin,Levocquin ( on the market now ); and the soon to be approved Zagam ( Sparfloxacin and Grepafloxacin. The last 3, share Trovan's 8 time more stronger property compared to the old Cipro, that PFE's newer Trovan has. May be Brad should consider selling his PFE at the present ? high. gg TA TA

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next